SynCore Biotechnology Co.,Ltd reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 4.48 million compared to TWD 1.48 million a year ago. Net loss was TWD 30.59 million compared to TWD 218.65 million a year ago. Basic loss per share from continuing operations was TWD 1.0106 compared to TWD 7.1117 a year ago.
For the nine months, sales was TWD 10.76 million compared to TWD 4.07 million a year ago. Net loss was TWD 106.93 million compared to TWD 378.46 million a year ago. Basic loss per share from continuing operations was TWD 3.481 compared to TWD 12.5017 a year ago.